N
Nexalin Technology D
D
NXL
4.16000
USD
0.24
(6.12%)
مغلق
حجم التداول
15,481
الربح لكل سهم
0
العائد الربحي
0
P/E
-6
حجم السوق
44,040,098
المقالات
العنوان: Nexalin Technology
القطاع: Healthcare
الصناعة: Medical Devices
Nexalin Technology Inc designs and develops innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.